AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Reluctance to Aim for a Lower SBO2
The separation between the three groups in my mind is remarkable. I mean, it's better than any of the other trials I think. Is there a reluctance to aim for a lower SBO2 and with the risk of undue harm from just from aiming for a number? Yes. That's a great question. And our whole effort in the design of the pilot trial was to look at the reasonable options that were within current clinical care.